PAP2B Polyclonal Antibody, Cy5 Conjugated
Product Specifications
Background
Catalyzes the conversion of phosphatidic acid (PA) to diacylglycerol (DG) . In addition it hydrolyzes lysophosphatidic acid (LPA), ceramide-1-phosphate (C-1-P) and sphingosine-1-phosphate (S-1-P) . The relative catalytic efficiency is LPA = PA > C-1-P > S-1-P. May be involved in cell adhesion and in cell-cell interactions.
Synonyms
LPP3; VCIP; Dri42; PAP2B; Lipid phosphate phosphohydrolase 3; PAP2-beta; Phosphatidate phosphohydrolase type 2b; Phosphatidic acid phosphatase 2b; PAP-2b; Vascular endothelial growth factor and type I collagen-inducible protein; PPAP2B
Gene ID
8613
Swiss Prot
O14495
Cellular Locus
Cytoplasm, Cell membrane
Host
Rabbit
Cross Reactivity
Mouse
Immunogen
241-311/311
Target
PAP2B
Clonality
Polyclonal
Isotype
IgG
Conjugation
Cy5
Source
KLH conjugated synthetic peptide derived from human PAP2B
Applications
WB, IF (IHC-P), IF (IHC-F), IF (ICC)
Purification
Purified by Protein A.
Excitation Emission
625,650nm/670nm
Concentration
1µg/µl
Dilution
WB (1:300-5000), IF (IHC-P) (1:50-200), IF (IHC-F) (1:50-200), IF (ICC) (1:50-200)
Buffer
Aqueous buffered solution containing 0.01M TBS (pH 7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol.
Modification
Unmodified
Storage Conditions
Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.
Gene ID URL
8613
Predicted Cross Reactivity
Human, Dog, Cow, Pig, Horse
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
GTR15090158 1 Vial
Lentiviral human DOCK3 shRNA (UAS) - Lentiviral human DOCK3 shRNA (UAS, iRFP) (25)
Ask
View Details